The patient’s medical history

According to the patient's medical history, he developed a blood clot as a result of chemical exposure at the plant where he worked. He went to the hospital to see if the injury to his bone marrow had impacted him. When he went to the hospital, the physicians saw bluish skin discoloration, swelling on the legs, and aches in the legs. Aside from these symptoms, the records revealed that the patient had chest pain and occasionally bloody mucous. Although work contributed to his condition, the patient's father was diagnosed with deep vein thrombosis. This reveals that the patient inherited blood clot from the father.

Given that the patient’s blood clotting condition had not reached a severe level, the doctors administered warfarin. The drug is taken through the mouth for a few weeks. Warfarin slows down the biochemical processes in the liver that uses vitamin K to make clotting factors stopping what causes the clot (Zitomersky, Levine, Atkinson, Harney, Verhave, M., Bousvaros, & Trenor III, 2013). The doctor recommended that the patient uses heparin until warfarin begins to work effectively. Zitomersky et al. (2013) emphasize that warfarin is effective for people with International Normalized Ration of around 1.0. This is required to reduce blood clotting for a long time.

The treatment of blood clotting involved pulmonary emboli in order to prevent clotting resulting from pulmonary. Pulmonary emboli helped the patient to reduce an increasing shortness of breath, weaknesses, and reduce a large amount of blood clot (Zitomersky et al., 2013). The doctor did administer the way the patient respond to the treatment to ensure that the treatment is effective for the condition.

As a follow-up care, the doctor ensured that he used computerized tomography to test any suspicion on the pulmonary embolus. In fact, the technology determines if there is a presence of a clot in the body. Also, the patient was required to avoid exposure to chemicals and other related elements.

References

Zitomersky, N. L., Levine, A. E., Atkinson, B. J., Harney, K. M., Verhave, M., Bousvaros, A., & Trenor III, C. C. (2013). Risk factors, morbidity, and treatment of thrombosis in children and young adults with active inflammatory bowel disease. Journal of pediatric gastroenterology and nutrition, 57(3), 343-347.